title: [Postoperative morbidities after modified posterior pelvic exenteration for ovarian cancer].
abstract: OBJECTIVE
  Complication and survival analysis of cytoreduction surgery with modified posterior pelvic exenteration in the surgical treatment of the ovarian malignant tumor.
  
  
  METHODS
  A retrospective monocentric study between 2000 and 2013 in Rhone-Alpes cancer treatment center. One hundred and fifty-two patients with ovarian cancer and treated by surgery with modified posterior pelvic exenteration were included. Complication in the 30 days after surgery was analysed by the Clavien-Dindo classification.
  
  
  RESULTS
  In our study, rate of global complication was 62.5% with a morbidity rate of grave complication of 7.9%. Our rate of complete resection was 82.2%. Three fistulas (2.2%) were found. On average, there was 6.6±1.8 (2-11) surgery gesture associated with Hudson resection during surgery. In univariate analysis, there was a statistic significant association between complication from the rank II of Clavien-Dindo classification and supraradical surgery, post-chemotherapy surgery, recurrent surgery, the resection of a diaphragmatic dome, and the partial gastric resection. This association was also observed with the number of surgical gesture associated with Hudson resection.
  
  
  CONCLUSIONS
  The main prognostic surgical factor in ovarian cancer is to obtain a no macroscopic residual disease. The modified posterior pelvic exenteration allowed to obtain it. Our study demonstrates a low rate of grave complication further to this type of surgery.
authors.affiliation: Département de chirurgie oncologique, centre de lutte contre le cancer Lyon et Rhône-Alpes, 28, rue Laennec, 69373 Lyon cedex 08, France. Electronic address: eminlaure@hotmail.fr.
authors.forename: L
authors.initials: L
authors.lastname: Emin
authors.affiliation: Département de chirurgie oncologique, centre de lutte contre le cancer Lyon et Rhône-Alpes, 28, rue Laennec, 69373 Lyon cedex 08, France.
authors.forename: P
authors.initials: P
authors.lastname: Meeus
authors.affiliation: Département de chirurgie oncologique, centre de lutte contre le cancer Lyon et Rhône-Alpes, 28, rue Laennec, 69373 Lyon cedex 08, France.
authors.forename: F
authors.initials: F
authors.lastname: Beurrier
authors.affiliation: Département de chirurgie oncologique, centre de lutte contre le cancer Lyon et Rhône-Alpes, 28, rue Laennec, 69373 Lyon cedex 08, France.
authors.forename: D
authors.initials: D
authors.lastname: Ferraioli
authors.affiliation: Département de chirurgie oncologique, centre de lutte contre le cancer Lyon et Rhône-Alpes, 28, rue Laennec, 69373 Lyon cedex 08, France.
authors.forename: N
authors.initials: N
authors.lastname: Carrabin
authors.affiliation: Département d'oncologie médicale, centre de lutte contre le cancer Lyon et Rhône-Alpes, 28, rue Laennec, 69373 Lyon cedex 08, France.
authors.forename: I
authors.initials: I
authors.lastname: Ray-Coquard
authors.affiliation: Département d'anatomopathologie, centre de lutte contre le cancer Lyon et Rhône-Alpes, 28, rue Laennec, 69373 Lyon cedex 08, France.
authors.forename: I
authors.initials: I
authors.lastname: Treilleux
authors.affiliation: Département de chirurgie oncologique, centre de lutte contre le cancer Lyon et Rhône-Alpes, 28, rue Laennec, 69373 Lyon cedex 08, France.
authors.forename: N
authors.initials: N
authors.lastname: Chopin
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002277:Carcinoma / Q000473:pathology / Q000601:surgery*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000473:pathology / Q000601:surgery*; D010385:Pelvic Exenteration / Q000009:adverse effects* / Q000379:methods; D011183:Postoperative Complications; D011379:Prognosis; D012189:Retrospective Studies; D055815:Young Adult
keywords: Cancer de l’ovaire; Chirurgie radicale; Complication; Complications; Exentération pelvienne postérieure modifiée; Modified posterior pelvic exenteration; Optimal cytoreduction; Ovarian cancer